Global Metabotropic Glutamate Receptor Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 156556
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.

Scope of the Report:

This report focuses on the Metabotropic Glutamate Receptor in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Metabotropic Glutamate Receptor is expected to grow at a CAGR of roughly 12.3% over the next five years, will reach 4 million US$ in 2023, from 2 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Serum Institute (India)

Sanofi SA (France)

Pfizer (USA)

Nuron Biotech (USA)

JN-International Medical (USA)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Polysaccharide Vaccines

Conjugate Vaccines

Combination Vaccines

Men B Vaccines

Market Segment by Applications, can be divided into

Meningitis

Septicemia

Others

There are 15 Chapters to deeply display the global Metabotropic Glutamate Receptor market.

Chapter 1, to describe Metabotropic Glutamate Receptor Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Metabotropic Glutamate Receptor, with sales, revenue, and price of Metabotropic Glutamate Receptor, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Metabotropic Glutamate Receptor, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Metabotropic Glutamate Receptor market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Metabotropic Glutamate Receptor sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Metabotropic Glutamate Receptor Introduction

1.2 Market Analysis by Type

1.2.1 Polysaccharide Vaccines

1.2.2 Conjugate Vaccines

1.2.3 Combination Vaccines

1.2.4 Men B Vaccines

1.3 Market Analysis by Applications

1.3.1 Meningitis

1.3.2 Septicemia

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Serum Institute (India)

2.1.1 Business Overview

2.1.2 Metabotropic Glutamate Receptor Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Serum Institute (India) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanofi SA (France)

2.2.1 Business Overview

2.2.2 Metabotropic Glutamate Receptor Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi SA (France) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pfizer (USA)

2.3.1 Business Overview

2.3.2 Metabotropic Glutamate Receptor Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Nuron Biotech (USA)

2.4.1 Business Overview

2.4.2 Metabotropic Glutamate Receptor Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Nuron Biotech (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 JN-International Medical (USA)

2.5.1 Business Overview

2.5.2 Metabotropic Glutamate Receptor Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 JN-International Medical (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Metabotropic Glutamate Receptor Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Metabotropic Glutamate Receptor Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Metabotropic Glutamate Receptor Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Metabotropic Glutamate Receptor Manufacturer Market Share in 2017

3.3.2 Top 6 Metabotropic Glutamate Receptor Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Metabotropic Glutamate Receptor Market Analysis by Regions

4.1 Global Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Regions

4.1.1 Global Metabotropic Glutamate Receptor Sales and Market Share by Regions (2013-2018)

4.1.2 Global Metabotropic Glutamate Receptor Revenue and Market Share by Regions (2013-2018)

4.2 North America Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

4.3 Europe Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

4.5 South America Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

5 North America Metabotropic Glutamate Receptor by Countries

5.1 North America Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Countries

5.1.1 North America Metabotropic Glutamate Receptor Sales and Market Share by Countries (2013-2018)

5.1.2 North America Metabotropic Glutamate Receptor Revenue and Market Share by Countries (2013-2018)

5.2 United States Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

5.3 Canada Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

5.4 Mexico Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

6 Europe Metabotropic Glutamate Receptor by Countries

6.1 Europe Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Countries

6.1.1 Europe Metabotropic Glutamate Receptor Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Metabotropic Glutamate Receptor Revenue and Market Share by Countries (2013-2018)

6.2 Germany Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

6.3 UK Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

6.4 France Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

6.5 Russia Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

6.6 Italy Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

7 Asia-Pacific Metabotropic Glutamate Receptor by Countries

7.1 Asia-Pacific Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Metabotropic Glutamate Receptor Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Metabotropic Glutamate Receptor Revenue and Market Share by Countries (2013-2018)

7.2 China Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

7.3 Japan Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

7.4 Korea Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

7.5 India Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

8 South America Metabotropic Glutamate Receptor by Countries

8.1 South America Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Countries

8.1.1 South America Metabotropic Glutamate Receptor Sales and Market Share by Countries (2013-2018)

8.1.2 South America Metabotropic Glutamate Receptor Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

8.3 Argentina Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

8.4 Colombia Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

9 Middle East and Africa Metabotropic Glutamate Receptor by Countries

9.1 Middle East and Africa Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Metabotropic Glutamate Receptor Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Metabotropic Glutamate Receptor Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

9.3 UAE Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

9.4 Egypt Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

9.5 Nigeria Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

9.6 South Africa Metabotropic Glutamate Receptor Sales and Growth Rate (2013-2018)

10 Global Metabotropic Glutamate Receptor Market Segment by Type

10.1 Global Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Metabotropic Glutamate Receptor Sales and Market Share by Type (2013-2018)

10.1.2 Global Metabotropic Glutamate Receptor Revenue and Market Share by Type (2013-2018)

10.2 Polysaccharide Vaccines Sales Growth and Price

10.2.1 Global Polysaccharide Vaccines Sales Growth (2013-2018)

10.2.2 Global Polysaccharide Vaccines Price (2013-2018)

10.3 Conjugate Vaccines Sales Growth and Price

10.3.1 Global Conjugate Vaccines Sales Growth (2013-2018)

10.3.2 Global Conjugate Vaccines Price (2013-2018)

10.4 Combination Vaccines Sales Growth and Price

10.4.1 Global Combination Vaccines Sales Growth (2013-2018)

10.4.2 Global Combination Vaccines Price (2013-2018)

10.5 Men B Vaccines Sales Growth and Price

10.5.1 Global Men B Vaccines Sales Growth (2013-2018)

10.5.2 Global Men B Vaccines Price (2013-2018)

11 Global Metabotropic Glutamate Receptor Market Segment by Application

11.1 Global Metabotropic Glutamate Receptor Sales Market Share by Application (2013-2018)

11.2 Meningitis Sales Growth (2013-2018)

11.3 Septicemia Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Metabotropic Glutamate Receptor Market Forecast (2018-2023)

12.1 Global Metabotropic Glutamate Receptor Sales, Revenue and Growth Rate (2018-2023)

12.2 Metabotropic Glutamate Receptor Market Forecast by Regions (2018-2023)

12.2.1 North America Metabotropic Glutamate Receptor Market Forecast (2018-2023)

12.2.2 Europe Metabotropic Glutamate Receptor Market Forecast (2018-2023)

12.2.3 Asia-Pacific Metabotropic Glutamate Receptor Market Forecast (2018-2023)

12.2.4 South America Metabotropic Glutamate Receptor Market Forecast (2018-2023)

12.2.5 Middle East and Africa Metabotropic Glutamate Receptor Market Forecast (2018-2023)

12.3 Metabotropic Glutamate Receptor Market Forecast by Type (2018-2023)

12.3.1 Global Metabotropic Glutamate Receptor Sales Forecast by Type (2018-2023)

12.3.2 Global Metabotropic Glutamate Receptor Market Share Forecast by Type (2018-2023)

12.4 Metabotropic Glutamate Receptor Market Forecast by Application (2018-2023)

12.4.1 Global Metabotropic Glutamate Receptor Sales Forecast by Application (2018-2023)

12.4.2 Global Metabotropic Glutamate Receptor Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Metabotropic Glutamate Receptor Picture

Table Product Specifications of Metabotropic Glutamate Receptor

Figure Global Sales Market Share of Metabotropic Glutamate Re

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery